论文部分内容阅读
１９７７年以来，作者行１５例肝移植中有１２例系肝恶性肿瘤行原位肝移植．无术中及术后即期死亡．存活３个月以上４例，半年以上２例，最长１例近９个月（２６４天）．主要死亡原因为肝功能衰竭、急性排斥、癌肿复发和感染．鉴于对肝癌作肝移植看法仍有分歧，作者提出肝癌新的分期，讨论了移植适应证与手术时机，认为肝移植适宜于肝癌Ｉ期ｂ型和Ⅱ期，也有倾向于更早期的．本文分析我国肝病行肝移植结果较差的原因有：癌恶性程度高又过于晚期，经验太少，我国尚未接受脑死亡概念，致供肝质量差和大部分病例未应用环孢素等．
Since 1977, the author of 12 cases of liver transplantation in 12 cases of liver malignancies orthotopic liver transplantation. No intraoperative and postoperative deaths occurred. 4 cases survived for more than 3 months, 2 cases more than half a year, and 1 case lasted for 9 months (264 days). The main cause of death was liver failure, acute rejection, cancer recurrence and infection. In view of the disagreement about liver transplantation for liver transplantation, the authors proposed a new stage of liver cancer, discussed the indications for transplantation and the timing of surgery, and believed that liver transplantation is suitable for stage I and stage B of liver cancer, and it also tends to be earlier. This paper analyzes the causes of poor liver transplantation in China. The reasons are: high and late malignant cancer, too little experience, China has not yet accepted the concept of brain death, resulting in poor liver quality and the absence of cyclosporine in most cases.